In terms of body weight reduction, tirzepatide at doses of 15 mg, 10 mg and 5 mg demonstrated greater efficacy than semaglutide at doses of 2.0 mg, 1.0 mg and 0.5 mg, respectively
Young people with obesity run a much higher risk of developing chronic, costly, life-shortening conditions like type 2 diabetes and cardiovascular and liver diseases
Notice that 40 units at 20 mg/mL delivers 8 mg of tirzepatide , not the 4 mg you would get at 10 mg/mL
Once TTC staining was complete, the brain sections were stored in 4% PFA overnight
Novo Nordisks case concerns its legal challenge to the manufacture and sale of compounded semaglutide products
See our compliance notice below for details